The Medicines (Products for Human Use — Fees) Regulations 1995

PART VIII REVOCATION, SAVINGS AND TRANSITIONAL PROVISIONS

Revocation and savings

22.—(1) Subject to paragraph (2), the following regulations (in this regulation called “the revoked Regulations”) are hereby revoked—

(a) the Medicines (Products for Human Use Fees) Regulations 1991(1);

(b) the Medicines (Products for Human Use Fees) Amendment Regulations 1992(2);

(c) the Medicines (Products for Human Use Fees) Amendment Regulations 1994(3).

(2) Paragraph (1) shall not affect—

(a) any written notice given or any suspension made under the revoked Regulations and any such notice or suspension shall have effect as if given or made under these Regulations; and

(b) any proceedings constituted under the revoked Regulations for the recovery of any fees due as debts to the Crown.

Transitional provisions

23.—(1) In relation to capital fees, these Regulations shad not apply to any application made before the date on which these Regulations come into force.

(2) In connection with any periodic fee payable under these Regulations, these Regulations shall not apply—

(a) to any marketing authorization or licence in respect of which the licensing authority has received written notice of surrender prior to the coming into force of these Regulations; or

(b) so as to impose any liability to pay a periodic fee in respect of any period prior to the coming into force of these Regulations.

(1)

S.I. 1991/1474; amended by S.I. 1992/756 and S.I. 1994/696.

(2)

S.I. 1992/756.

(3)

S.I. 1994/696.